{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Staphylococcal+Infections", "query": { "condition": "Staphylococcal Infections" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 157, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Staphylococcal+Infections&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-21T23:18:58.524Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04775953", "title": "DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Staphylococcal Bacteraemia" ], "interventions": [ { "name": "Cefazolin", "type": "DRUG" }, { "name": "Dalbavancin", "type": "DRUG" }, { "name": "Daptomycin", "type": "DRUG" }, { "name": "Nafcillin", "type": "DRUG" }, { "name": "Oxacillin", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 200, "start_date": "2021-04-22", "completion_date": "2023-12-01", "has_results": true, "last_update_posted_date": "2024-12-10", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Sacramento, California • Torrance, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04775953" }, { "nct_id": "NCT01861457", "title": "Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Infectious Disease" ], "interventions": [ { "name": "Nozin® Nasal Sanitizer®", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 39, "start_date": "2013-01", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2024-10-02", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01861457" }, { "nct_id": "NCT02566928", "title": "Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Methicillin-Resistant Staphylococcus Aureus", "Recurrence", "Staphylococcal Skin Infections", "Antibiotic Resistance" ], "interventions": [ { "name": "2% mupirocin ointment", "type": "DRUG" }, { "name": "Chlorhexidine wash", "type": "OTHER" }, { "name": "Hygiene protocol", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "OTHER", "BEHAVIORAL" ], "sponsor": "Clinical Directors Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "7 Years to 70 Years" }, "enrollment_count": 278, "start_date": "2015-10", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 6, "location_summary": "Brooklyn, New York • New York, New York • The Bronx, New York", "locations": [ { "city": "Brooklyn", "state": "New York" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02566928" }, { "nct_id": "NCT01827358", "title": "Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Staphylococcal Infection" ], "interventions": [ { "name": "Mupirocin calcium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "24 Months", "sex": "ALL", "summary": "Up to 24 Months" }, "enrollment_count": 155, "start_date": "2014-04-30", "completion_date": "2016-06-21", "has_results": true, "last_update_posted_date": "2017-07-07", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 6, "location_summary": "Atlanta, Georgia • Baltimore, Maryland • Kansas City, Missouri + 3 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01827358" }, { "nct_id": "NCT01431326", "title": "Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adenovirus", "Anesthesia", "Anxiety", "Anxiolysis", "Autism", "Autistic Disorder", "Bacterial Meningitis", "Bacterial Septicemia", "Benzodiazepine", "Bipolar Disorder", "Bone and Joint Infections", "Central Nervous System Infections", "Convulsions", "Cytomegalovirus Retinitis", "Early-onset Schizophrenia Spectrum Disorders", "Epilepsy", "General Anesthesia", "Gynecologic Infections", "Herpes Simplex Virus", "Infantile Hemangioma", "Infection", "Inflammation", "Inflammatory Conditions", "Intra-abdominal Infections", "Lower Respiratory Tract Infections", "Migraines", "Pain", "Pneumonia", "Schizophrenia", "Sedation", "Seizures", "Skeletal Muscle Spasms", "Skin and Skin-structure Infections", "Treatment-resistant Schizophrenia", "Urinary Tract Infections", "Withdrawal", "Sepsis", "Gram-negative Infection", "Bradycardia", "Cardiac Arrest", "Cardiac Arrhythmia", "Staphylococcal Infections", "Nosocomial Pneumonia", "Neuromuscular Blockade", "Methicillin Resistant Staphylococcus Aureus", "Endocarditis", "Neutropenia", "Headache", "Fibrinolytic Bleeding", "Pulmonary Arterial Hypertension", "CMV Retinitis", "Hypertension", "Chronic Kidney Diseases", "Hyperaldosteronism", "Hypokalemia", "Heart Failure", "Hemophilia", "Heavy Menstrual Bleeding", "Insomnia" ], "interventions": [ { "name": "The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Benjamin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 3520, "start_date": "2011-11", "completion_date": "2019-11", "has_results": false, "last_update_posted_date": "2023-09-06", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 43, "location_summary": "Anchorage, Alaska • Little Rock, Arkansas • La Jolla, California + 37 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431326" }, { "nct_id": "NCT02208063", "title": "A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacteremia" ], "interventions": [ { "name": "Telavancin", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" }, { "name": "Daptomycin", "type": "DRUG" }, { "name": "Synthetic penicillin", "type": "DRUG" }, { "name": "Cefazolin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cumberland Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 121, "start_date": "2014-12", "completion_date": "2018-04-12", "has_results": true, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02208063" }, { "nct_id": "NCT02296320", "title": "Study of the Efficacy and Safety of MEDI4893", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Staphylococcus Aureus Pneumonia" ], "interventions": [ { "name": "MEDI4893", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 213, "start_date": "2014-10-10", "completion_date": "2018-10-02", "has_results": true, "last_update_posted_date": "2019-12-23", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Detroit, Michigan", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02296320" }, { "nct_id": "NCT00758862", "title": "The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Secondarily Infected Traumatic Lesions (SITL)", "Impetigo" ], "interventions": [ { "name": "2% TD1414 Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2008-12", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2025-03-13", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 1, "location_summary": "College Station, Texas", "locations": [ { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00758862" }, { "nct_id": "NCT00419991", "title": "Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Staphylococcal Infections" ], "interventions": [ { "name": "Tigecycline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CPL Associates", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 10, "start_date": "2007-01", "completion_date": "2008-05", "has_results": false, "last_update_posted_date": "2011-06-22", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 3, "location_summary": "Huntsville, Alabama • Marietta, Georgia • Cumberland, Maryland", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Cumberland", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00419991" }, { "nct_id": "NCT02684422", "title": "Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Methicillin-Resistant Staphylococcus Aureus", "Cystic Fibrosis" ], "interventions": [ { "name": "Intervention N/A. Observational study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "4 Years to 99 Years" }, "enrollment_count": 48, "start_date": "2015-07", "completion_date": "2021-12", "has_results": false, "last_update_posted_date": "2022-01-20", "last_synced_at": "2026-05-21T23:18:58.524Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Chapel Hill, North Carolina • Seattle, Washington", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02684422" } ] }